Tenderwize
Retour à la recherche

Contrat de remise pour le golimumab

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jul 27, 2027 · 248 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Golimumab (ATC-Code: L04AB06).

53/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

53 / 100

Complexité

62 / 100

Facteurs de risque

The notice expressly allows replacement of open-house agreements by exclusive rebate contracts, with automatic terminat...

Electronic submission is not permitted, and the notice states that receipt by AOK Niedersachsen is decisive.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jul 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply of pharmaceutical products containing the active substance golimumab, ATC code L04AB06.
  • Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V using an open-house model.
Afficher le résumé complet

Open-house, non-exclusive pharmaceutical rebate agreement for medicines containing golimumab (ATC L04AB06) in Germany. AOK Niedersachsen intends to offer identical contractual terms to all eligible pharmaceutical entrepreneurs or eligible pharmaceutical entrepreneur groups, without a selection decision or individual negotiations. Contracts may begin on the first day of a month during the term and end no later than 30 September 2027. The initial entry deadline for a 1 October 2025 start has passed, but later entry remains possible subject to the contractual notice periods. Contract documents must be requested from AOK Niedersachsen and were not provided for analysis.

Risques

The notice expressly allows replacement of open-house agreements by exclusive rebate contracts, with automatic terminat...

Electronic submission is not permitted, and the notice states that receipt by AOK Niedersachsen is decisive.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • A pharmaceutical entrepreneur placing medicinal products on the German market must have its seat in Germany, another EU Member State, or another EEA contracting state, as...
  • Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the relevant medicinal products.

Eligibility

  • Only eligible pharmaceutical entrepreneurs within the meaning of Section 4(18) AMG, or groups of such entrepreneurs, may conclude agreements for the offered medicinal products.

Critères d'attribution

Lot 1

Price is identified as the award criterion; no description or numeric weighting is provided.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Golimumab pharmaceutical rebate agreement

Non-exclusive open-house rebate agreement for medicinal products containing golimumab (ATC L04AB06). AOK Niedersachsen will apply uniform conditions and may conclude agreements with all eligible market participants. Contracting can occur during the maximum 24-month period, but agreements may end automatically if exclusive rebate contracts enter into force.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Sep 2025 - Sep 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jul 27, 2027

Détails de la procédure

Date de publication
04 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
511702-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy